scispace - formally typeset
Journal ArticleDOI

Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics.

Reads0
Chats0
TLDR
As in contact allergy, T cell‐mediated hypersensitivity in non‐immediate (NI) cutaneous adverse drug reactions (CADRs) to antibiotics is considered to be lifelong, but, in this setting, patch tests have rarely been repeated after long time intervals.
Abstract
SummaryBackground As in contact allergy, T cell-mediated hypersensitivity in non-immediate (NI) cutaneous adverse drug reactions (CADRs) to antibiotics is considered to be lifelong, but, in this setting, patch tests have rarely been repeated after long time intervals. Objective To evaluate the long-term reproducibility of positive patch test reactions to antibiotics in patients with NI CADRs. Methods Fifty-six patients with NI CADRs to antibiotics who had relevant positive reactions during patch testing were invited to repeat patch tests with a similar antibiotic series 2–15 years thereafter. Results Twenty patients were included (9 males and 11 females; mean age 54.6 years): 18 with maculopapular exanthema, 1 with drug hypersensitivity syndrome, and 1 with acute generalized exanthematous pustulosis. Results were reproducible in 17 of 20 patients after a mean interval of 6.0 years (range 2–14.7 years). Concerning β-lactams, 7 of 8 patients remained positive for aminopenicillins, 4 of 4 for isoxazolyl penicillins, and 1 for cefoxitin. Patch test results were also reproducible for clindamycin in 5 of 7 patients, for vancomycin in 1 patient, and for spiramycin in 1 patient. Reproducibility was not affected by the time interval between tests, sex, or age at testing. Conclusions In the context of NI CADRs, we showed high reproducibility of positive patch test reactions to various antibiotics, even after several years.

read more

Citations
More filters
Journal ArticleDOI

Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

TL;DR: The decision to use a drug challenge as a diagnostic or delabeling tool in a patient with a severe delayed IM-ADR should weigh the risk-benefit ratio, balancing the severity and priority for the treatment of the underlying, and the availability of alternative efficacious and safe treatments.
Journal ArticleDOI

Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.

TL;DR: Patch tests are a simple and safe diagnostic tool, which in the case of severe reactions should be used as the first line of investigation, however, patch tests are less sensitive than intradermal tests, which are preferable in subjects with mild reactions.
References
More filters
Journal ArticleDOI

Drug allergy: an updated practice parameter.

TL;DR: Predictable reactions are subdivided into drug intolerance, drug idiosyncrasy, drug allergy, and pseudoallergic reactions, which are estimated to comprise approximately 80% of all ADRs.
Journal ArticleDOI

General considerations for skin test procedures in the diagnosis of drug hypersensitivity

TL;DR: This poster presents a poster presented at the European Congress of Allergy and Clinical Immunology/Allergology, entitled “Evaluating the immune defences of the immune system against fungal infections”.
Journal ArticleDOI

Diagnosis of nonimmediate reactions to beta-lactam antibiotics.

TL;DR: Clinical and immunohistological studies and analysis of drug‐specific T‐cell clones obtained from the circulating blood and the skin suggest that a type‐IV (cell‐mediated) pathogenic mechanism may be involved in some nonimmediate reactions such as maculopapular or bullous rashes and acute generalized exanthematous pustulosis.
Related Papers (5)